Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase NA 2Phase 3 1Phase 1 1

Status

Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Colorectal Neoplasms 1431Pancreatic Neoplasms 664Colonic Neoplasms 655Carcinoma, Hepatocellular 632Rectal Neoplasms 571Stomach Neoplasms 547Esophageal Neoplasms 384Liver Neoplasms 280Breast Neoplasms 278Neoplasms 243Gastrointestinal Neoplasms 214Lung Neoplasms 175Prostatic Neoplasms 137Barrett Esophagus 127Colonic Polyps 115Cholangiocarcinoma 114Motor Activity 101Ovarian Neoplasms 75Head and Neck Neoplasms 73Neoplasm Metastasis 64Adenoma 61Uterine Cervical Neoplasms 58Anus Neoplasms 54Anastomotic Leak 54Carcinoma, Non-Small-Cell Lung 53Colorectal Neoplasms, Hereditary Nonpolyposis 51Biliary Tract Neoplasms 51Postoperative Complications 49Urinary Bladder Neoplasms 47Esophageal Squamous Cell Carcinoma 47

Interventions

folfirinox 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Resectable Pancreatic Cancer × Gastrointestinal × Clear all
NCT05788744 2026-03-27

CIRCPAC

Copenhagen University Hospital at Herlev

Phase NA Recruiting
1,000 enrolled
Gastrointestinal

Resectable Pancreatic Cancer

NCT04472910 2026-03-12

NeoPancOne

University Health Network, Toronto

Phase NA Active not recruiting
84 enrolled
Gastrointestinal

Resectable Pancreatic Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡